Transfer of host T-cell membrane HLA-DR and CD25 to target cells by human retroviruses

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 3, 1998, Pages 196-202

  Saifuddin, Mohammed ^a   Crnich, Chris ^a   Long, Timothy ^a   Saarloos, Mary Nel ^a   Spear, Gregory T ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

Cellular activation; HLA DR; Human retrovirus; IL 2 receptor

Indexed keywords

CYCLOHEXIMIDE; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MEMBRANE PROTEIN; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0032032926     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199803010-00002     Document Type: Article

References (44)

1. Cooper NR, Welsh RM Jr. Antibody and complement-dependent viral neutralization. Springer Semin Immunopathol 1979;2:285-310.
2. Cranage MP, Ashworth LAE, Greenaway PJ, Murphey-Corb M, Desrosiers RC. AIDS vaccine development. Nature 1992;355: 685-6.
3. Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, Bolognesi DP. The ability of certain SIV vaccines to provoke reactions against normal cells. Science 1992;255:292-3.
4. Spear GT, Takefman DM, Sullivan BL, Landay AL, Jennings MB, Carlson JR. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology 1993;195:475-80.
5. Stott EJ, Kitchin PA, Page M, et al. Anti-cell antibody in macaques. Nature 1991;353:393.
6. Arthur LO, Bess JW Jr, Sowder RC II, et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992;258:1935-8.
7. Orentas RJ, Hildreth JEK. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses 1993;9:1157-65.
8. Saifuddin M, Parker CJ, Peeples ME, et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 1995a;182:501-9.
9. Spear GT, Lurain NS, Parker CJ, Ghassemi M, Payne GH, Saifuddin M. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated envelope viruses: human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J Immunol 1995;155:4376-81.
10. Franke EK, Yuan HEH, Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994;372:359-62.
11. Thali M, Bukovsky A, Kondo E, et al. Functional association of cyclophilin A with HIV-1 virions. Nature 1994;372:363-5.
12. Gomez MB, Hildreth JEK. Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1. J Virol 1995;69:4628-32.
13. Schglovitova O, Scanio V, Fais S, et al. Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells. Arch Virol 1995;140:951-8.
14. Morikawa S, Tatsumi E, Baba M, Harada T, Yasuhira K. Two E-rosette-forming lymphoid cell lines. Int J Cancer 1978;21:166-70.
15. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemic T Cells. Nature 1981;294:770-1.
16. Banapour B, Sernatinger J, Levy JA. The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology 1986;152:268-71.
17. Saifuddin M, Ghassemi M, Patki C, Parker CJ, Spear GT. Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis. AIDS Res Hum Retroviruses 1994;10:829-37.
18. Lenard J, Rabson A, Vanderoef R. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc Natl Acad Sci USA 1993;90:158-62.
19. Sullivan BL, Knopoff EJ, Saifuddin M, et al. Susceptibility of HIV-1 plasma virus to complement-mediated lysis: evidence for a role in clearance of virus in vivo. J Immunol 1996;157:1791-8.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature 1970;227:680-5.
21. Saifuddin M, Landay AL, Ghassemi M, Patki C, Spear GT. HTLV-I activates complement leading to increased binding to complement receptor-positive cells. AIDS Res Hum Retroviruses 1995b;11:1115-22.
22. Gessain A, Saal F, Morozov V, et al. Characterization of HTLV-I isolates and T lymphoid cell lines derived from French west Indian patients with tropical spastic paraparesis. Int J Cancer 1989;43: 327-33.
23. Uchiyama T, Hori T, Tsudo M, et al. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest 1985;76:446-53.
24. Yamada Y. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood 1983;61:192-9.
25. Lando Z, Sarin P, Megson M, et al. Association of human T-cell leukemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor. Nature 1983;305:733-6.
26. Sinangil F, Loyter A, Volsky DJ. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching. Fed Eur Biochem Soc 1988;239:88-92.
27. Minami Y, Kono T, Miyazaki T, Taniguchi T. The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 1993;11:245-67.
28. Odum N, Martin PJ, Schieven GL, Hansen JA, Ledbetter JA. Signal transduction by HLA class II antigens expressed on activated T cells. Eur J Immunol 1991;21:123-9.
29. Smith KA. Interleukin 2: inception, impact, and implications. Science 1988;240:1169-76.
30. Spertini F, Chatila T, Geha RS. Signals delivered via MHC class II molecules synergize with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells. J Immunol 1992;149:65-70.
31. Waldmann TA. The interleukin-2 receptor. J Biologic Chemist 1991;266:2681-4.
32. Takeshita T, Asao H, Ohtani K, et al. Cloning of the γ chain of the human IL-2 receptor. Science 1992;257:379-82.
33. Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 1993;73:5-8.
34. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
35. Saksela K, Muchmore E, Giradr M, Fultz P, Baltimore D. High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J Virol 1993;67:7423-7.
36. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
37. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
38. Seto A, Isono T, Ogawa K. Infection of inbred rabbits with cell-free HTLV-I. Leuk Res 1991;15:105-10.
39. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
40. Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nature Med 1996;6:625-9.
41. Saarloos M-N, Sullivan BL, Czerniewski MA, Parameswar KD, Spear GT. Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1. J Virol 1997;71:1640-3.
42. Hollsberg P, Ausubel LJ, Hafler DA. Human T cell lymphotropic virus type I-induced T cell activation: resistance to TGF-β1-induced suppression. J Immunol 1994;153:566-73.
43. Jacobson DL, McCutchan JA, Spechko PL, et al. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J Infect Dis 1991;163: 240-6.
44. Kamoun M, Zerva L, Sloan S, Zmijewski C, Monos D, Trinchieri G. Induction of HLA class II molecules on human T cells: relationship to immunoregulation and the pathogenesis of AIDS. DNA Cell Biol 1992;11:265-8.